Kjell Magne Tveit

Professor II - Department of Oncology
Image of Kjell Magne Tveit
Norwegian version of this page
Phone +47-22119125
Mobile phone 91649163
Username
Visiting address Ullernchausseen 70 0372 OSLO
Postal address Postboks 4950 Nydalen 0424 OSLO
Tags: Nordic

Publications

  • Guren, Tormod Kyrre; Thomsen, Maria; Kure, Elin H.; Sorbye, Halfdan; Glimelius, Bengt; Pfeiffer, Per; Sigurdsson, Fridbjörn; Lothe, Inger Marie Bowitz; Larsen, Astrid Marie; Skovlund, Eva; Christoffersen, Thoralf & Tveit, Magne Kjell (2017). Cetuximab in treatment of metastatic colorectal cancer: Final survival analyses and extended RAS data from the NORDIC-VII study. British Journal of Cancer.  ISSN 0007-0920.  116(10), s 1271- 1278 . doi: 10.1038/bjc.2017.93
  • Thomsen, Maria; Guren, Marianne; Skovlund, Eva; Glimelius, Bengt; Hjermstad, Marianne Jensen; Johansen, Julia S.; Kure, Elin Wenche Hegland; Sorbye, Halfdan; Pfeiffer, Per; Christoffersen, Thoralf; Guren, Tormod Kyrre & Tveit, Magne Kjell (2017). Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status. European Journal of Cancer.  ISSN 0959-8049.  81, s 26- 35 . doi: 10.1016/j.ejca.2017.04.026
  • Kjersem, Janne Beathe; Thomsen, Maria; Guren, Tormod Kyrre; Hamfjord, Julian; Carlsson, G; Gustavsson, B.; Ikdahl, Tone; Indrebø, Gunnar; Pfeiffer, P; Lingjærde, Ole Christian; Tveit, Magne Kjell; Wettergren, Y & Kure, Elin H. (2016). AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin. The Pharmacogenomics Journal.  ISSN 1470-269X.  16(3), s 272- 279 . doi: 10.1038/tpj.2015.54
  • Mezheyeuski, Artur; Lindh, Maja Bradic; Guren, Tormod Kyrre; Dragomir, Anca; Pfeiffer, Per; Kure, Elin H.; Andersen, Tone Ikdahl; Skovlund, Eva; Corvigno, Sara; Strell, Carina; Pietras, Kristian; Pontén, Fredrik; Mulder, Jan; Qvortrup, Camilla; Portyanko, Anna; Tveit, Magne Kjell; Glimelius, Bengt; Sorbye, Halfdan & Ostman, Arne (2016). Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer. OncoTarget.  ISSN 1949-2553.  7(27), s 41948- 41958 . doi: 10.18632/oncotarget.9632 Full text in Research Archive. Show summary
  • Tarpgaard, Line Schmidt; Ørum-Madsen, Maj Sofie; Christensen, Ib Jarle; Nordgaard, Cathrine; Noer, Julie; Guren, Tormod Kyrre; Glimelius, Bengt; Sorbye, Halfdan; Andersen, Tone Ikdahl; Kure, Elin H.; Tveit, Magne Kjell; Nielsen, Hans Jørgen; Pfeiffer, Per; Brünner, Nils & Moreira, José M.A. (2016). TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer. OncoTarget.  ISSN 1949-2553.  7(37), s 59441- 59457 . doi: 10.18632/oncotarget.11118
  • Thomsen, Maria; Kersten, Christian; Sorbye, Halfdan; Skovlund, Eva; Glimelius, Bengt; Pfeiffer, Per; Johansen, Julia S.; Kure, Elin H.; Andersen, Tone Ikdahl; Tveit, Magne Kjell; Christoffersen, Thoralf & Guren, Tormod Kyrre (2016). Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer. OncoTarget.  ISSN 1949-2553.  7(46), s 75013- 75022 . doi: 10.18632/oncotarget.12601
  • Dueland, Svein; Guren, Tormod Kyrre; Hagness, Morten; Glimelius, Bengt; Line, Pål Dag; Pfeiffer, Per; Foss, Aksel & Tveit, Magne Kjell (2015). Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases from Colorectal Cancer?. Annals of Surgery.  ISSN 0003-4932.  261(5), s 956- 960 . doi: 10.1097/SLA.0000000000000786
  • Gustavsson, Bengt; Carlsson, Göran; Machover, David; Petrelli, Nicholas; Roth, Arnaud; Schmoll, Hans-Joachim; Tveit, Magne Kjell & Gibson, Fernando (2015). A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clinical colorectal cancer.  ISSN 1533-0028.  14(1), s 1- 10 . doi: 10.1016/j.clcc.2014.11.002
  • Tarpgaard, Line Schmidt; Christensen, Ib J.; Høyer-Hansen, Gunilla; Lund, Ida K.; Guren, Tormod Kyrre; Glimelius, Bengt; Sorbye, Halfdan; Tveit, Magne Kjell; Nielsen, Hans Jørgen; Moreira, José M.A.; Pfeiffer, Per & Brünner, Nils (2015). Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab. International Journal of Cancer.  ISSN 0020-7136.  137(10), s 2470- 2477 . doi: 10.1002/ijc.29476
  • Dueland, Svein; Hagness, Morten; Line, Pål Dag; Guren, Tormod Kyrre; Tveit, Magne Kjell & Foss, Aksel (2014). Is Liver Transplantation an Option in Colorectal Cancer Patients with Nonresectable Liver Metastases and Progression on All Lines of Standard Chemotherapy?. Annals of Surgical Oncology.  ISSN 1068-9265. . doi: 10.1245/s10434-014-4137-0
  • Guren, Marianne; Undseth, Christine; Rekstad, Bernt Louni; Brandengen, Morten; Dueland, Svein; Spindler, Karen-Lise Garm; Glynne-Jones, Rob & Tveit, Magne Kjell (2014). Reirradiation of locally recurrent rectal cancer: A systematic review. Radiotherapy and Oncology.  ISSN 0167-8140.  113(2), s 151- 157 . doi: 10.1016/j.radonc.2014.11.021
  • Hauglann, Beate Kristin; Saltyte Benth, Jurate; Fosså, Sophie Dorothea; Tveit, Magne Kjell & Dahl, Alv A (2014). A controlled cohort study of long-term income in colorectal cancer patients. Supportive Care in Cancer.  ISSN 0941-4355. . doi: 10.1007/s00520-014-2258-4
  • Hauglann, Beate Kristin; Saltyte Benth, Jurate; Fosså, Sophie Dorothea; Tveit, Magne Kjell & Dahl, Alv A (2014). A controlled cohort study of sickness absence and disability pension in colorectal cancer survivors. Acta Oncologica.  ISSN 0284-186X.  53(6), s 735- 743 . doi: 10.3109/0284186X.2013.844354
  • Holme, Øyvind; Løberg, Magnus; Kalager, Mette; Bretthauer, Michael; Hernan, Miguel A.; Aas, Eline; Eide, Tor Jacob; Skovlund, Eva; Schneede, Jørn; Tveit, Magne Kjell & Hoff, Geir (2014). Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality A Randomized Clinical Trial. Journal of the American Medical Association (JAMA).  ISSN 0098-7484.  312(6), s 606- 615 . doi: 10.1001/jama.2014.8266
  • Kjersem, Janne Beathe; Ikdahl, Tone; Lingjærde, Ole Christian; Guren, Tormod Kyrre; Tveit, Magne Kjell & Kure, Elin H. (2014). Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment. Molecular Oncology.  ISSN 1574-7891.  8(1), s 59- 67 . doi: 10.1016/j.molonc.2013.09.001
  • Kjersem, Janne Beathe; Skovlund, Eva; Ikdahl, Tone; Guren, Tormod Kyrre; Kersten, Christian; Dalsgaard, Astrid Marie; Yilmaz, Mette Karen; Fokstuen, Tone; Tveit, Magne Kjell & Kure, Elin H. (2014). FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab. BMC Cancer.  ISSN 1471-2407.  14 . doi: 10.1186/1471-2407-14-340 Full text in Research Archive.
  • Leon, Otilia; Guren, Marianne; Hagberg, Oskar; Glimelius, Bengt; Dahl, Olav; Havsteen, Hanne; Naucler, Gisela; Svensson, Christer; Tveit, Magne Kjell; Jakobsen, Anders; Pfeiffer, Per; Wanderås, Eva Hoff; Ekman, Tor; Lindh, Birgitta; Balteskard, Lise; Frykholm, Gunilla & Johnsson, Anders (2014). Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines. Radiotherapy and Oncology.  ISSN 0167-8140.  113(3), s 352- 358 . doi: 10.1016/j.radonc.2014.10.002
  • Tarpgaard, Line Schmidt; Guren, Tormod Kyrre; Glimelius, Bengt; Christensen, Ib J.; Pfeiffer, Per; Kure, Elin H.; Sorbye, Halfdan; Andersen, Tone Ikdahl; Yilmaz, Mette; Johansen, Julia S. & Tveit, Magne Kjell (2014). Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: Results from the NORDIC VII Study. PLoS ONE.  ISSN 1932-6203.  9(2:e87746) . doi: 10.1371/journal.pone.0087746
  • Wiig, Johan N.; Giercksky, Karl-Erik & Tveit, Magne Kjell (2014). Intraoperative radiotherapy for locally advanced or locally recurrent rectal cancer: Does it work at all?. Acta Oncologica.  ISSN 0284-186X.  53(7), s 865- 876 . doi: 10.3109/0284186X.2014.895037
  • Åsli, Linn Merete; Kvaløy, Stein Olav; Jetne, Vidar; Myklebust, Tor Åge; Levernes, Sverre G.; Tveit, Magne Kjell; Green, Tor Olav & Johannesen, Tom Børge (2014). Utilization of radiation therapy in norway after the implementation of the national cancer plan - A national, population-based study. International Journal of Radiation Oncology, Biology, Physics.  ISSN 0360-3016.  90(3), s 707- 714 . doi: 10.1016/j.ijrobp.2014.06.059
  • Sveen, Anita; Nesbakken, Arild; Ågesen, Trude Holmeide; Guren, Marianne; Tveit, Magne Kjell; Skotheim, Rolf Inge & Lothe, Ragnhild A (2013). Anticipating the Clinical Use of Prognostic Gene Expression-Based Tests for Colon Cancer Stage II and III: Is Godot Finally Arriving?. Clinical Cancer Research.  ISSN 1078-0432.  19(24), s 6669- 6677 . doi: 10.1158/1078-0432.CCR-13-1769
  • Bentzen, Anne Gry; Guren, Marianne; Wanderås, Eva Hoff; Frykholm, Gunilla; Tveit, Magne Kjell; Wilsgaard, Tom; Dahl, Olav & Balteskard, Lise (2012). Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National Cohort. International Journal of Radiation Oncology, Biology, Physics.  ISSN 0360-3016.  83(2), s E173- E180 . doi: 10.1016/j.ijrobp.2011.12.062
  • Tveit, Magne Kjell; Guren, Tormod Kyrre; Glimelius, Bengt; Pfeiffer, Per; Sorbye, Halfdan; Pyrhonen, Seppo; Sigurðsson, Friðbjörn; Kure, Elin H.; Andersen, Tone Ikdahl; Skovlund, Eva; Fokstuen, Tone; Hansen, Flemming; Hofsli, Eva; Birkemeyer, Elke; Johnsson, Anders; Starkhammar, Hans; Yilmaz, Mette Karen; Keldsen, Nina; Erdal, Anne Berit Rødal; Dajani, Olav; Dahl, Olav & Christoffersen, Thoralf (2012). Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII Study. Journal of Clinical Oncology.  ISSN 0732-183X.  30(15), s 1755- 1762 . doi: 10.1200/JCO.2011.38.0915
  • Brændengen, Morten; Tveit, Magne Kjell; Hjermstad, Marianne Jensen; Johansson, Hemming; Berglund, Åke; Brandberg, Yvonne & Glimelius, Bengt (2012). Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study. European Journal of Cancer.  ISSN 0959-8049.  48(6), s 813- 819 . doi: 10.1016/j.ejca.2011.06.035
  • Hamfjord, Julian; Stangeland, Astrid Marie; Hughes, Timothy; Skrede, Martina; Tveit, Magne Kjell; Andersen, Tone Ikdahl & Kure, Elin H. (2012). Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing. PLoS ONE.  ISSN 1932-6203.  7(4) . doi: 10.1371/journal.pone.0034150
  • Kjersem, Janne Beathe; Andersen, Tone Ikdahl; Guren, Tormod Kyrre; Skovlund, Eva; Sorbye, Halfdan; Hamfjord, Julian; Pfeiffer, Per; Glimelius, Bengt; Kersten, Christian; Solvang, Hiroko Kato; Tveit, Magne Kjell & Kure, Elin H. (2012). Let-7 miRNA-binding site polymorphism in the KRAS 3 ' UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab. BMC Cancer.  ISSN 1471-2407.  12 . doi: 10.1186/1471-2407-12-534
  • Myklebust, Mette Pernille; Li, Zhiping; Tran, Thai H.; Rui, Hallgeir; Knudsen, Erik S.; Elsaleh, Hany; Fluge, Øystein; Vonen, Barthold; Myrvold, Helge Elliot; Leh, Sabine; Tveit, Magne Kjell; Pestell, Richard G. & Dahl, Olav (2012). Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. British Journal of Cancer.  ISSN 0007-0920.  107(10), s 1684- 1691 . doi: 10.1038/bjc.2012.463
  • Bornholdt, Jette; Friis, Stine; Godiksen, Sine; Poulsen, Steen S.; Santoni-Rugiu, Eric; Bisgaard, Hanne C.; Lothe, Inger M Bowitz; Andersen, Tone Ikdahl; Tveit, Magne Kjell; Johnson, Egil; Kure, Elin H. & Vogel, Lotte K. (2011). The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer.  ISSN 1471-2407.  11 . doi: 10.1186/1471-2407-11-65
  • Brændengen, Morten; Tveit, Magne Kjell; Bruheim, Kjersti; Småstuen, Milada C; Berglund, Åke & Glimelius, Bengt (2011). Late Patient-Reported Toxicity After Preoperative Radiotherapy or Chemoradiotherapy in Nonresectable Rectal Cancer: Results From a Randomized Phase III Study. International Journal of Radiation Oncology, Biology, Physics.  ISSN 0360-3016.  81(4), s 1017- 1024 . doi: 10.1016/j.ijrobp.2010.07.007
  • Hamfjord, Julian; Stangeland, Astrid Marie; Skrede, Martina; Tveit, Magne Kjell; Andersen, Tone Ikdahl & Kure, Elin H. (2011). Wobble-enhanced ARMS Method for Detection of KRAS and BRAF Mutations. Diagnostic molecular pathology.  ISSN 1052-9551.  20(3), s 158- 165 . doi: 10.1097/PDM.0b013e31820b49e2
  • Bruheim, K; Guren, MG; Skovlund, E; Hjermstad, Marianne Jensen; Dahl, O; Frykholm, Gunilla; Carlsen, Erik & Tveit, KM (2010). Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics.  ISSN 0360-3016.  76(4), s 1005- 1011 . doi: 10.1016/j.ijrobp.2009.03.010
  • Bruheim, Kjersti; Guren, Marianne; Dahl, Alv A; Skovlund, Eva; Balteskard, Lise; Carlsen, Erik; Fosså, Sophie Dorothea & Tveit, Magne Kjell (2010). Sexual function in males after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics.  ISSN 0360-3016.  76(4), s 1012- 1017 . doi: 10.1016/j.ijrobp.2009.03.075
  • BRUHEIM, KJERSTI; Guren, Marianne; Skovlund, Eva; Hjermstad, Marianne Jensen; Dahl, Olav; Frykholm, Gunilla; Carlsen, Erik & Tveit, Magne Kjell (2010). Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics.  ISSN 0360-3016.  76(4), s 1005- 1011 . doi: 10.1016/j.ijrobp.2009.03.010
  • Bruheim, Kjersti; Tveit, Magne Kjell; Skovlund, Eva; Balteskard, Lise; Carlsen, Erik; Fosså, Sophie Dorothea & Guren, Marianne (2010). Sexual function in females after radiotherapy for rectal cancer. Acta Oncologica.  ISSN 0284-186X.  49(6), s 826- 832 . doi: 10.3109/0284186X.2010.486411
  • Brændengen, Morten; Tveit, Magne Kjell; BRUHEIM, KJERSTI; Småstuen, Milada C; Berglund, Åke & Glimelius, Bengt (2010). Late patient reported toxicity after preoperative radiotherapy or chemoradiotherapy in non-resectable rectal cancer. Results from a randomized phase III study. International Journal of Radiation Oncology, Biology, Physics.  ISSN 0360-3016. . doi: 10.1016/j.ijrobp.2010.07.007
  • Fluge, Øystein; Gravdal, K; Carlsen, E; Carlsen, Erik; Vonen, Barthold; Kjellevold, K; Refsum, S; Lilleng, R; Eide, Tor J.; Halvorsen, TB; Tveit, KM; Tveit, Kjell Magne; Otte, AP; Akslen, LA & Dahl, O (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer.  ISSN 0007-0920.  101(8), s 1282- 1289 . doi: 10.1038/sj.bjc.6605333
  • Baatrup, Gunnar; Endreseth, Birger H.; Isaksen, Vidar; Kjellmo, Åse; Kjellmo, Åse; Tveit, Kjell Magne & Nesbakken, Arild (2009). Preoperative staging and treatment options in T1 rectal adenocarcinoma. Acta Oncologica.  ISSN 0284-186X.  48(3), s 328- 342 . doi: 10.1080/02841860802657243
  • Dahl, Olav; Fluge, Øystein; Carlsen, Erik; Wiig, Johan N; Myrvold, Helge E; Vonen, Barthold; Podhorny, Nina; Bjerkeset, Ottar; Eide, Tor Jacob; Halvorsen, T & Tveit, Kjell Magne (2009). Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncologica.  ISSN 0284-186X.  48(3), s 368- 376 . doi: 10.1080/02841860902755244
  • Jetne, Vidar; Kvaløy, Stein Olav; Smeland, Sigbjørn; Johannessen, Tom Børge & Tveit, Magne Kjell (2009). Bruk av stråleterapi i Helse Sør-Øst. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  129(24), s 2602- 2605
  • Selzer-Plon, Joanna; Bornholdt, Jette; Friis, Stine; Bisgaard, Hanne C.; Lothe, Inger Marie Bowitz; Tveit, Magne Kjell; Kure, Elin H.; Vogel, Ulla & Vogel, Lotte K. (2009). Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis. BMC Cancer.  ISSN 1471-2407.  9 . doi: 10.1186/1471-2407-9-201 Show summary
  • Skovbjerg, Hanne; Anthonsen, Dorrit; Lothe, Inger M Bowitz; Tveit, Magne Kjell; Kure, Elin H. & Vogel, Lotte K. (2009). Collagen mRNA levels changes during colorectal cancer carcinogenesis. BMC Cancer.  ISSN 1471-2407.  9 . doi: 10.1186/1471-2407-9-136 Show summary
  • Tveit, KM; Balteskard, L & Dahl, Olav (2009). Gastrointestinal kreft, I: Olav Dahl; Gustav Lehne; Ingebjørg Baksaas; Stein Kvaløy & Thoralf Christoffersen (red.),  Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave.  Farmakologisk inst., Fakultetsdivisjonen Rikshospitalet, Det med. fakultet, Universitetet i Oslo, Oslo Universitetssykehus HF - Radiumhospitalet, Seksjon for onkologi, IFI, MOF, Universitetet i Bergen.  ISBN 978-82-9923312-5.  Kap. 27.  s 363 - 375
  • Glimelius, Bengt; Sørbye, Halfdan; Balteskard, L; Byström, P; Pfeiffer, P; Tveit, KM; Heikkilä, R; Keldsen, N; Albertsson, M; Starkhammar, H; Garmo, H & Berglund, Å (2008). A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer. Annals of Oncology.  ISSN 0923-7534.  19(5), s 909- 914 . doi: 10.1093/annonc/mdm588 Show summary
  • Qvortrup, C; Yilmaz, M; Øgreid, Dagfinn; Berglund, A; Balteskard, L; Ploen, J.; Fokstuen, T; Starkhammar, H; Sørbye, Halfdan; Tveit, KM & Pfeiffer, P (2008). Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil. Annals of Oncology.  ISSN 0923-7534.  19, s 1154- 1159 . doi: 10.1093/annonc/mdn002 Show summary
  • Brændengen, Morten; Tveit, Magne Kjell; Berglund, A; Birkemeyer, E; Frykholm, Gunilla; Pahlman, L; Wiig, JN; Bystrom, P; Bujko, K & Glimelius, B (2008). Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. Journal of Clinical Oncology.  ISSN 0732-183X.  26, s 3687- 3694 . doi: 10.1200/JCO.2007.15.3858
  • Skjelbred, Camilla Furu; Sæbø, Mona; Li, Karin Brekke; Lothe, Inger Marie Bowitz; Hagen, Per Chr.; Johnsen, Egil; Tveit, Kjell Magne & Kure, Elin H. (2008). CYP1A2 164 A -> C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas. Anticancer Research.  ISSN 0250-7005.  28(4C), s 2289- 2295 Show summary
  • Lorentzen, Anders; Vogel, Lotte K.; Lewinsky, Rikke H.; Sæbø, Mona; Skjelbred, Camilla Furu; Godiksen, Sine; Hoff, Geir; Tveit, Kjell Magne; Lothe, Inger Marie Bowitz; Ikdahl, Tone; Kure, Elin H. & Mitchelmore, Cathy (2007). Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma. BMC Cancer.  ISSN 1471-2407.  7(192), s 1- 8 . doi: 10.1186/1471-2407-7-192 Show summary
  • Skjelbred, Camilla Furu; Sæbø, Mona; Hjartaker, Anette; Grotmol, T.; Hansteen, Inger-Lise; Tveit, Kjell Magne; Hoff, Geir & Kure, Elin H. (2007). Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer.  ISSN 1471-2407.  7(228), s 1- 11 . doi: 10.1186/1471-2407-7-228 Show summary
  • Glimelius, B; Dahl, O; Cedermark, B; Jakobsen, A; Bentzen, SM; Starkhammar, H; Grunberg, H; Hultborn, R; Albertsson, M; Pahlman, L & Tveit, Magne Kjell (2005). Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncologica.  ISSN 0284-186X.  44(8), s 904- 912
  • Glimelius, Bengt; Dahl, Olav; Cedermark, Björn; Jakobsen, Anders; Benzen, Søren M.; Starkhammar, Hans; Grönberg, Henrik; Hultborn, Ragnar; Albertsson, Maria; Påhlman, Lars & Tveit, Kjell-Magne (2005). Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncologica.  ISSN 0284-186X.  44(8), s 904- 912 . doi: 10.1080/02841860500355900
  • Guren, MG; Eriksen, MT; Wiig, JN; Carlsen, E; Nesbakken, Arild; Sigurdsson, HK; Wibe, A & Tveit, Magne Kjell (2005). Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. European Journal of Surgical Oncology.  ISSN 0748-7983.  31(7), s 735- 742
  • Guren, Tormod Kyrre; Christoffersen, Thoralf; Thoresen, G. Hege; Wisløff, Finn Georg B; Tveit, Magne Kjell & Dajani, Olav (2005). Antitumormidler rettet mot tyrosinkinaser. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  (Årg. 125, nr 22), s 3115- 3119
  • Pfeiffer, P; Sorbye, H; Ehrsson, H; Fokstuen, T; Mortensen, JP; Baltesgard, L; Tveit, Magne Kjell; Ogreid, D; Starkhammar, H; Wallin, I; Qvortrup, C & Glimelius, B (2005). Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil. Annals of Oncology.  ISSN 0923-7534.  17(2), s 252- 258
  • Tveit, Magne Kjell (2005). Svulster i tynntarm, tykktarm, endetarm og anus, I: Rolf Kåresen & Erik Wist (red.),  Kreftsykdommer - en basisbok for helsepersonell.  Gyldendal Akademisk.  ISBN 82-05-33494-3.  2 - 5.  s 187 - 189
  • Tveit, Magne Kjell & Kataja, VV (2005). ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer. Annals of Oncology.  ISSN 0923-7534.  16, s 20- 21
  • Sørbye, Halfdan; Glimelius, Bengt; Berglund, Å; Fokstuen, T; Tveit, Kjell Magne; Brændengen, M; Øgreid, D & Dahl, Olav (2004). Multicentre phase II study of Nordic 5-fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology.  ISSN 0732-183X.  22, s 31-38
  • Guren, Marianne Grønlie; Schneede, Jørn; Tveit, Kjell Magne; Ueland, Per Magne; Nexø, Ebba & Dueland, Svein (2004). Biochemical signs of impaired cobalamin status during and after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics.  ISSN 0360-3016.  60, s 807- 813
  • Guren, Marianne G; Dueland, Svein; Skovlund, Eva; Fosså, Sophie Dorothea; Poulsen, J. P. & Tveit, Kjell Magne (2003). Quality of life during radiotherapy for rectal cancer. European Journal of Cancer.  ISSN 0959-8049.  39(5), s 587- 594
  • Kringen, Pedro; Egedal, Sidsel; Pedersen, Jan Christian; Harbitz, Thorstein B.; Tveit, Kjell Magne; Berg, Kåre; Børresen-Dale, Anne-Lise & Andersen, Tone Ikdal (2002). BRCA1 mutation screening using restriction endonuclase fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system. Electrophoresis.  ISSN 0173-0835.  23(24), s 4085- 4091 Show summary
  • Wiig, J. N.; Tveit, Magne Kjell; Poulsen, J. P.; Olsen, Dag Rune & Giercksky, Karl-Erik (2002). Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiotherapy and Oncology.  ISSN 0167-8140.  62(2), s 207- 213
  • Wiig, J. N.; Tveit, Magne Kjell; Poulsen, J. P.; Olsen, Dag Rune & Giercksky, Karl-Erik (2002). Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT)be of additional benefit? A prospective study. Radiotherapy and Oncology.  ISSN 0167-8140.  62(2), s 207- 213
  • Christoffersen, Thoralf & Tveit, Kjell Magne (2001). Legemidler i neoplasmebehandlingen, I: Anne Marie Vennerød (red.),  Norsk legemiddelhåndbok.  Norsk legemiddelhåndbok i/s.  s 663 - 696
  • Tveit, Kjell Magne & Christoffersen, Thoralf (2001). Neoplasmer, I: Anne Marie Vennerød (red.),  Norsk legemiddelhåndbok.  Norsk legemiddelhåndbok i/s.  s 91 - 110
  • Guren, Marianne G; Wiig, J. N.; Dueland, Svein; Tveit, Magne Kjell; Fosså, Sophie Dorothea; Wæhre, Håkon. & Giercksky, Karl-Erik (2001). Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer. European Journal of Surgical Oncology.  ISSN 0748-7983.  27, s 645- 651
  • Guren, Marianne G; Wiig, J. N.; Dueland, Svein; Tveit, Magne Kjell; Fosså, Sophie Dorothea; Wæhre, Håkon. & Giercksky, Karl-Erik (2001). Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer. European Journal of Surgical Oncology.  ISSN 0748-7983.  27(7), s 645- 651 Show summary
  • Tveit, KM; Dahl, Olav & Kvaløy, Stein O (1999). Behandling med cytostatica, I: Olav Dahl; Thoralf Christoffersen; Stein O Kvaløy & Ingebjørg Baksaas (red.),  Cytostatika. Medikamentell kreftbehandling [6. utg.].  Institutt for farmakoterapi , UiO/Den Norske Kreftforening.  s 33 - 40
  • Tveit, KM; Giercksky, K-E & Dahl, Olav (1999). Gastrointestinal kreft, I: Olav Dahl; Thoralf Christoffersen; Stein O Kvaløy & Ingebjørg Baksaas (red.),  Cytostatika. Medikamentell kreftbehandling [6. utg.].  Institutt for farmakoterapi , UiO/Den Norske Kreftforening.  s 310 - 317
  • Tveit, Kjell Magne; Bergan, A.; Dahl, Olav; Giercksky, K-E; Myrvold, H; Norum, J; Skarstein, Arne & Solheim, K (1999). Kolorektalcancer og analcancer, I: [Mangler fornavn] [Mangler etternavn] (red.),  Kolorektalcancer og analcancer En veiledning for leger.  Norsk Gastrointestinal Cancer Gruppe /Den Norske Kreftforening.  -.  s 1 - 67
  • Geisler, Jürgen; Geisler, Stephanie; Lønning, Per Eystein; Småland, Rune; Tveit, Kjell Magne; Refsum, Helga & Ueland, Per Magne (1998). Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients. Clinical Cancer Research.  ISSN 1078-0432.  4, s 2125- 2128
  • Suo, Zhenha; Emilens, E.; Tveit, Magne Kjell & Nesland, Jahn M (1998). Expression of the type 1 protein tyrosine kinases in benign and malignant breast leasions. Histopathology.  ISSN 0309-0167.  33, s 514- 521
  • Andersen, T.E.; Eiken, Hans Geir; Couch, F. J; Kaada, G.; Skrede, Martina; Johnsen, Hege Britt; Aloysius, T. A.; Tveit, Magne Kjell; Traneberg, Lisbeth; Dørum, Anne; Møller, Per; Weber, Barbara & Børresen-Dale, Anne-Lise (1998). Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening. Human Mutation.  ISSN 1059-7794.  11, s 166- 174
  • Christoffersen, Thoralf & Tveit, Magne Kjell (1998). Neoplasmer, I: Anne Marie Vennerød (red.),  Norsk legemiddelhåndbok.   ISBN 82-90732-06-6.  s 151 - 197
  • Helle, S.I.; Geisler, J.; Poulsen, J. P.; Hestad, Kjetil; Meadows, K.; Collins, W.; Tveit, Magne Kjell; Viste, A.; Holly, J.M.P. & Lønning, Per Eystein (1998). Microencapsulated Octreotide in Advanced Gastrointestinal and Pancreatic Cancer: a Phase I Study. British Journal of Cancer.  ISSN 0007-0920.  78(1), s 14- 20
  • Andersen, Tone Ikdahl; Wooster, R.; Laake, Kirsten; Collins, N.; Warren, W.; Skrede, Martina; Eeles, R.; Tveit, Magne Kjell; Johnston, S. R. D.; Dowsett, M.; Møller, Per; Stratton, M.; Børresen-Dale, Anne-Lise & Olsen, Arne (1997). Screening for ESR mutations in breast and ovarian cancer patients. Human Mutation.  ISSN 1059-7794.  9, s 531- 536
  • Tveit, Magne Kjell & Harbitz, Torstein B. (1997). Randomized controlled trial of postoperative radiotherapy and short-term time-sheduled 5-fluorouracil against surgery above in the treatment of Dukes B and C rectal cancer. British Journal of Surgery.  ISSN 0007-1323.  84, s 1130- 1135
  • Tveit, Magne Kjell; Wiig, J. N.; Olsen, Dag Rune; Storaas, A.; Poulsen, J. P. & Giercksky, Karl-Erik (1997). Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer. Radiotherapy and Oncology.  ISSN 0167-8140.  44, s 277- 282
  • Christoffersen, Thoralf & Tveit, Kjell Magne (1996). Neoplasmer (Kapittel om medikamentell kreftbehandling), I: Anne Marie Vennerød (red.),  Norsk Legemiddelhåndbok, 7.utg.  Oslo.  s 135 - 176
  • Fosså, Sophie Dorothea; Tveit, Magne Kjell; Børmer, Ole P.; Moxnes, Aud; Jørgensen, Nils Petter; Ørjaseter, H & Kristoffersen, Doris Tove (1988). Relative bioavailability of oral low dose methotrexate. A comparison of 2 different formulations. European Journal of Clinical Pharmacology.  ISSN 0031-6970.  34(5), s 517- 519

View all works in Cristin

  • Skarstein, Arne; Tveit, Kjell Magne; Bergan, A.; Solheim, K; Norum, J.; Myrvold, H.; Giercksky, K-E & Dahl, Olav (1998). Standardprogram ved colorectalcancer. [Mangler utgivernavn].

View all works in Cristin

  • Kure, Elin H.; Hamfjord, Julian; Larsen, Astrid Marie; Tveit, Magne Kjell & Ikdahl, Tone (2012). KRAS mutational test for metastatic colorectal cancer patients: not just a technical problem. Expert Review of Molecular Diagnostics.  ISSN 1473-7159.  12(4), s 327- 328 . doi: 10.1586/ERM.12.29
  • Tarpgaard, Line Schmidt; Guren, Tormod Kyrre; Glimelius, Bengt; Pfeiffer, Per; Kure, Elin; Yilmaz, Mette Karen; Sorbye, Halfdan; Keldsen, Nina; Skovlund, Eva; Johansen, Julia S. & Tveit, Magne Kjell (2012). Plasma concentrations of YKL-40 in chemo-naive patients with metastatic colorectal cancer treated with FLOX with or without cetuximab: Results from the NORDIC VII study. Journal of Clinical Oncology.  ISSN 0732-183X.  30(15)
  • Tveit, Magne Kjell; Guren, Tormod Kyrre; Glimelius, Bengt; Pfeiffer, P; Sørbye, Halfdan; Pyrhönen, S; Kure, Elin H.; Ikdahl, Tone; Skovlund, Eva & Christoffersen, Thoralf (2010). Randomized phase III study of 5-fluorouracil/folinate/oxaliplatin given continuously or intermittently with or without cetuximab, as first-line treatment of metastatic colorectal cancer: the Nordic VII study (NCT00145314), by the Nordic colorectal cancer biomodulation group. Annals of Oncology.  ISSN 0923-7534.  21, s 9- 9
  • Bjørnbeth, Bjørn Atle; Labori, Knut Jørgen; Buanes, Trond; Tveit, Magne Kjell; Nordeng, Hans Jørgen; Drolsum, Anders & Carlsen, Erik (2005). Onkologisk-kirurgisk poliklinikk.
  • Glimelius, Bengt; Sørbye, Halfdan; Balteskard, L; Byström, P; Pfeiffer, P; Tveit, KM; Heikkilä, R; Albertsson, M; Starkhammar, H; Dahl, Olav & Berglund, Å (2005). A randomised phase III multicenter trial comparing irinotecan in combination with 5FU and folinic acid (FU/FA) given according to the Nordic bolus schedule to irinotecan in combination with 5FU/FA given according to the bolus/infused de Gramont schedule, in patients with metastatic colorectal cancer.
  • Dahl, Olav; Tveit, Kjell Magne; Carlsen, Erik; Wiig, Johan; Myrvold, Helge E.; Gauperaa, Tore; Skarstein, Arne; Podhorny, Nina; Bjerkeset, Ottar & Eide, Tor Jacob (2003). Only colon cancer patients with Dukes stage C benefit from adjuvant chemotherapy with 5-fluorouracil and levamisole among 425 patients with operable colorectal cancer in a Norwegian randomised study.
  • Glimelius, Bengt; Cedermark, B.; Dahl, Olav; Tveit, Kjell Magne; Jakobsen, Anders & Bentzen, S. (2003). Adjuvant chemotherapy in colorectal cancer: Joint analyses of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
  • Sørbye, Halfdan; Glimelius, Bengt; Berglund, Åke; Fokstuen, Tone; Tveit, Kjell Magne; Brændengen, Morten; Øgreid, Dagfinn & Dahl, Olav (2003). Nordic 5-fluorouracil/folinic acid bolus schedule combined with oxaliplatin (FLOX) as first-line treatment to metastatic colorectal cancer.
  • Tveit, KM; Bergan, A.; Dahl, Olav; Giercksky, K-E; Myrvold, H; Norum, J; Skarstein, Arne & Solheim, K (1999). Kolorektalcancer og analcancer. En veiledning for leger.
  • Tveit, Magne Kjell (1997). Adjuvant behandling ved operabel tykktarms- og endetarmskreft. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  20:117, s 2991- 2992
  • Tveit, Magne Kjell (1997). Cytostatica hos primærlegen?. Tidsskrift for Den norske legeforening.  ISSN 0029-2001.  27:117, s 3911- 3912

View all works in Cristin

Published Apr. 13, 2011 2:54 PM - Last modified June 6, 2016 1:43 PM